Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Hyperinsulinism × Solutions × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Keratosis, Actinic 2 Hemangioma 2 Squamous Intraepithelial Lesions 1 Skin Neoplasms 1 Sarcoma 1 Neoplasms 1 Melanoma 1 Insulinoma 1 Hyperinsulinism 1 Hematologic Neoplasms 1 Congenital Hyperinsulinism 1 Carcinoma, Squamous Cell 1 Carcinoma, Basal Cell 1 Breast Neoplasms 1

Interventions

pasireotide 1 fluorodopa F 18 1 Solutions 1 Saline Solution 1 Injections 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03053284 2021-05-14

Pasireotide in Hyperinsulinemic Hypoglycemia

Montefiore Medical Center

Phase 2 Withdrawn

Hyperinsulinism, Insulinoma, Congenital Hyperinsulinism

Data powered by HemOnc (CC BY 4.0) Colophon ⚡